Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Figure 1. Analytic framework and key questions

Flow chart depicts analytic framework and key questions for review.  For details, go to [D] Text Description.

[D] Select for Text Description.

Critical key questions:

  1. Does screening for bacterial vaginosis during pregnancy in asymptomatic pregnant women reduce adverse pregnancy outcomes for those at:
    1. Low risk for preterm delivery?
    2. Average risk for preterm delivery?
    3. High risk for preterm delivery?
  2. Does treatment of bacterial vaginosis during pregnancy in asymptomatic pregnant women reduce adverse pregnancy outcomes for those at:
    1. Low risk for preterm delivery?
    2. Average risk for preterm delivery?
    3. High risk for preterm delivery?
  3. What adverse effects does the screening and/or treatment of bacterial vaginosis have on pregnancy outcomes?

Note: KQ = key question.

Return to Document

 

AHRQ Advancing Excellence in Health Care